Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Biomarkers
Treatment
Clinical Care
Prevention
View all Topics
Conferences
AAIC 2023
BNA 2023
AD/PD 2023
ARUK 2023
CTAD 2022
AAIC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Alzheimer’s Disease
2:53
Roadblocks to the use of blood-based biomarkers in clinical care
Suzanne Schindler
• 19 Jul 2023
1:55
Amyloid prediction models for use in the general population
Julia Neitzel
• 18 Jul 2023
1:18
Increasing participation of underrepresented groups in clinical trials
Doris Molina-Henry
• 18 Jul 2023
2:41
Visual versus quantitative analysis of tau-PET
Alexis Moscoso
• 7 Aug 2023
1:08
Why Alzheimer’s disease research is focusing on tau
Sonya Miller
• 17 Jul 2023
0:56
Blood-based biomarkers for treatment monitoring in Alzheimer’s disease
Suzanne Schindler
• 19 Aug 2023
2:04
The promise of tau aggregation inhibitors in dementia
Sonya Miller
• 17 Jul 2023
1:44
Genes differentially associated with Alzheimer’s disease based on sex and APOE status
Michael Belloy
• 19 Jul 2023
1:35
Barriers to participation of underrepresented groups in clinical trials
Doris Molina-Henry
• 18 Jul 2023
1:56
Advantages of tau-PET compared to amyloid-PET
Alexis Moscoso
• 7 Aug 2023
3:31
The Phase III LUCIDITY trial: a tau aggregation inhibitor in patients with Alzheimer’s disease
Sonya Miller
• 17 Aug 2023
4:21
The effect of APOE on the lipidome of individual brain cell types
Femke Feringa
• 19 Jul 2023
2:01
Fibrin-targeting immunotherapy in Alzheimer’s Disease
Katerina Akassoglou
• 18 Jul 2023
1:57
Plasma p-tau181 to identify Alzheimer’s disease-related co-pathology in DLB
Carla Abdelnour
• 17 Jul 2023
2:05
Recognizing and managing pain in the context of cognitive impairment
Christina Jensen-Dahm
• 17 Jul 2023
2:37
Time gap between amyloid- and tau-PET positivity in preclinical disease
Alexis Moscoso
• 7 Aug 2023
Previous
1
2
3
4
5
6
7
8
…
59
Next